Representative before the EPO
Partner/Owner

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 103 EP applications Cameron Marshall has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 22, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14160481

Alphavirus vectors for RSV and PIV vaccines

IPC classification:
A61K 39/295, A61K 39/215, A61K 39/155, A61K 39/145, A61K 39/12, A61K 39/02, A61K 39/00, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Nicholas James Finnie, Novartis Pharma AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14187138

Detoxified Escherichia coli immunogens

IPC classification:
A61K 39/108
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
No opposition filed within time limit
EP14189933

Alphavirus vectors for influenza virus vaccines

IPC classification:
A61K 39/295, A61K 39/215, A61K 39/155, A61K 39/145, A61K 39/12, A61K 39/02, A61K 39/00, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Nicholas James Finnie, Novartis Pharma AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12874745

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

IPC classification:
A61K 31/216, A61K 31/185
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
PATENT GRANTED
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION WITHDRAWN
EP13747515

VACCINES FOR SEROGROUP X MENINGOCOCCUS

IPC classification:
A61K 39/095
Applicant:
Institut Pasteur
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12756826

EUGLOBULIN-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE

IPC classification:
G01N 33/48, C12Q 1/56, C12Q 1/37
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Roberto Pistolesi, Dragotti & Associati Srl
Status:
The patent has been granted
EP13732536

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/21
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13745892

AUTO-ANTIGEN BIOMARKERS FOR LUPUS

IPC classification:
G01N 33/564
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728300

POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF

IPC classification:
C07C 69/732, C07C 69/675, C07C 69/533, C07C 67/31, C07C 67/03, C07C 57/15, C07C 51/16, C07C 29/09, C07C 11/167, C07C 1/24
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14192835

A variant form of urate oxidase and use thereof

IPC classification:
A61K 47/48, A61K 38/44, C12N 9/72, C12N 9/06
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13857455

METHODS OF ADMINISTERING AND EVALUATING NITROGEN SCAVENGING DRUGS FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY

IPC classification:
A61K 49/00, A61K 31/19
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
EXAMINATION IN PROGRESS
EP15156612

Variant forms of urate oxidase and use thereof

IPC classification:
A61K 47/48, C12N 9/06
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14714825

TOBACCO INBRED AND HYBRID PLANTS AND USES THEREOF

IPC classification:
C12N 15/82, C12N 9/10, A01H 5/12
Applicant:
North Carolina State University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15182862

NEISSERIAL ANTIGENIC PEPTIDES

IPC classification:
G01N 33/569, G01N 33/53, A61K 48/00, A61K 39/40, A61K 39/095, C07K 16/12, C07K 14/22, C12N 15/31
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Marcus Jonathan William Dalton, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14769502

THIOESTERASES AND CELLS FOR PRODUCTION OF TAILORED OILS

IPC classification:
C12N 9/00, C12N 5/02, C12N 5/00, C12P 7/64
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14785518

PARALLELIZED SAMPLE HANDLING

IPC classification:
B81B 7/04
Applicant:
California Institute of Technology
Applicant:
University of Chicago
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14814315

METHODS FOR ANALYZING CYSTEAMINE COMPOSITIONS

IPC classification:
B01D 15/32, G01N 30/89, G01N 30/34, G01N 30/16, G01N 30/04, G01N 21/33
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14813132

DELAYED RELEASE CYSTEAMINE BEAD FORMULATION

IPC classification:
A01N 33/08, A61K 9/32
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14744940

A CARTRIDGE, CARTRIDGE READER AND METHOD FOR PREVENTING REUSE OF THE CARTRIDGE

IPC classification:
B01L 3/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14784356

LABELLING COMPOUNDS AND THEIR USE IN ASSAYS

IPC classification:
C12Q 1/68, C07F 17/02
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14798760

REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES

IPC classification:
A61K 39/00, C07K 1/18
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis International AG
Agent:
Florian Bielefeldt, Novartis AG
Status:
EXAMINATION REQUESTED
EP15734548

HIGH-PROTEIN FOOD PRODUCTS MADE USING HIGH-PROTEIN MICROALGAE

IPC classification:
A23L 23/00, A23L 2/02, A23L 2/68, A23L 2/66, A23L 33/10
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16731641

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61P 27/02, A61P 35/00, A61P 25/28, A61P 19/02, A61P 29/00, A61P 11/06, A61P 1/00, C12N 1/20, A61K 35/74
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP16731639

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61K 35/745, A61P 35/00, A61P 25/28, A61P 19/02, A61P 29/00, A61P 11/06, A61P 1/00, C12N 1/20, A61K 35/74
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP15857339

METHODS OF TREATING HUNTINGTON'S DISEASE USING CYSTEAMINE COMPOSITIONS

IPC classification:
A61K 31/13, A61K 31/145, A61P 25/28
Agent:
Boult Wade Tennant Ltd
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15805141

MANUFACTURE OF SURFACTANT-CONTAINING COMPOSITIONS

IPC classification:
A61K 9/107, A61K 47/26
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis International AG
Status:
The patent has been granted
EP16731640

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61K 35/745, A61P 35/00, A61P 25/28, A61P 19/02, A61P 29/00, A61P 11/06, A61P 1/00, C12N 1/20, A61K 35/74
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP16709814

LIPID EXTRACTION PROCESSES

IPC classification:
C11C 1/08, C11C 1/02, C11C 1/00, C11B 3/00, C11B 1/10, A61K 35/612, A23J 7/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17180246

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

IPC classification:
A61K 9/19, A61K 47/18, A61K 39/00, A61K 47/26, A61K 9/00, C07K 16/28, A61K 39/395, A61P 1/00
Applicant:
Millennium Pharmaceuticals, Inc.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
Request for examination was made
EP16731642

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
C12N 1/20, A61P 25/28, A61P 19/02, A61P 29/00, A61P 11/06, A61P 1/00, A61K 35/74
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP16797021

IMPROVED URICASE SEQUENCES AND METHODS OF TREATMENT

IPC classification:
C12N 15/53, C12N 15/09, C12N 9/06, A61P 19/06, A61K 38/44, A61K 38/43
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
AstraZeneca PLC
Status:
Request for examination was made
EP17742523

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61K 9/19, A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP17742524

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61K 9/19, A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP17204215

ROSEBURIA FLAGELLIN AND IMMUNE MODULATION

IPC classification:
C07K 14/195, A23P 10/30, A61P 37/00, A61P 29/00, A61P 19/00, A61P 17/00, A61P 1/00, A61K 48/00, A61K 39/02, A61K 38/16
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17709911

COMPOSITIONS COMPRISING BACTERIAL BLAUTIA STRAINS FOR TREATING VISCERAL HYPERSENSITIVITY

IPC classification:
A61P 29/00, A61P 1/14, A61K 9/00, A61K 35/741
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP17192612

METHOD FOR FLOW CYTOMETRY LINKED WITH ELEMENTAL ANALYSIS

IPC classification:
H01J 49/04, G01J 3/443, G01N 15/14, H01J 49/26
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16774748

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16778888

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Teva Pharmaceuticals International GmbH
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16849686

METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER

IPC classification:
A61K 39/395, A61K 31/282, C07K 16/46, C07K 16/28, C07K 16/22
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16854550

METHODS AND APPLICATIONS OF GENE FUSION DETECTION IN CELL-FREE DNA ANALYSIS

IPC classification:
G06F 19/20, C12N 15/11, C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16854492

POPULATION BASED TREATMENT RECOMMENDER USING CELL FREE DNA

IPC classification:
G01N 33/574, G01N 33/48, C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17818220

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61P 29/00, A61P 1/14, A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP18153975

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61P 35/00, C12N 1/00, A61K 35/744
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17716332

TGFBETA1-BINDING IMMUNOGLOBULINS AND USE THEREOF

IPC classification:
C07K 16/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16858388

ANTIBODY/T-CELL RECEPTOR CHIMERIC CONSTRUCTS AND USES THEREOF

IPC classification:
C12N 15/63, C12N 15/62, A61K 35/17, A61K 38/17, C07K 14/725
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18167277

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61P 27/02, A61P 35/00, A61P 25/28, A61P 19/02, A61P 29/00, A61P 11/06, A61P 1/00, A61K 35/74
Applicant:
4D Pharma Research Ltd.
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17732001

USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES

IPC classification:
C07K 16/22, A61P 21/00, A61K 39/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP16826873

COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOUNDS, DISORDERS, AND DISEASES OF THE SKIN

IPC classification:
C07K 14/47, C12N 9/02, C07K 19/00, A61P 17/00, A61K 38/39, A61K 48/00, C07K 14/78, C12N 15/869
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16862931

AUTOMATED SAMPLE QUALITY ASSESSMENT

IPC classification:
G01N 33/48, G01N 33/50, G06F 19/10, G06F 19/28
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16871665

HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61P 25/16, A61P 25/00, A61K 31/12, A61K 31/00, A61K 9/72, A61P 25/28
Applicant:
University of California
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16815858

OIL-IN-WATER EMULSIONS INCLUDING RETINOIC ACID

IPC classification:
A61K 31/203, A61K 31/07, A61K 39/39, A61K 47/44, A61K 39/00, A61K 33/00
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis International AG
Status:
Request for examination was made
EP17202898

IMMUNE MODULATION

IPC classification:
A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18173280

STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS

IPC classification:
A61K 39/00, C07K 16/28, A61K 47/26, A61K 47/18, A61K 9/00, A61K 9/19, A61K 39/395
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
The application has been published
EP18181342

TREATMENT OF BREAST TUMORS WITH A RAPAMYCIN DERIVATIVE IN COMBINATION WITH AN AROMATASE INHIBITOR

IPC classification:
A61P 35/00, A61K 31/4545, A61K 31/58, A61K 31/366, A61K 31/451, A61K 31/5685, A61K 31/4196, A61K 45/06, A61K 31/436
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP17748191

CANCER EVOLUTION DETECTION AND DIAGNOSTIC

IPC classification:
G06F 19/18, C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18166185

PRLR-SPECIFIC ANTIBODY AND USES THEREOF

IPC classification:
A61K 31/00, C12N 15/13, C12N 5/18, A61P 35/00, A61K 39/395, C07K 16/28
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18192502

METHODS OF TREATING CHRONIC PAIN

IPC classification:
C07K 16/18, A61P 29/00, A61P 25/00, C07K 16/26, A61K 39/395
Applicant:
Teva Pharmaceuticals International GmbH
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18198271

METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES

IPC classification:
C12N 15/90, A61K 48/00, C12N 9/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18199852

MICROALGAE ADAPTED FOR HETEROTROPHIC CULTURE CONDITIONS

IPC classification:
C12R 1/89, C12P 7/64, C12N 9/24, C12N 1/36
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18202101

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A23L 33/135, A61K 39/00, A61K 31/00, A61K 9/19, A23C 9/152, A61K 35/74, A61K 39/08, A61P 27/02, A61P 11/06, A61P 29/00, A61P 19/00
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17783335

METHODS FOR EARLY DETECTION OF CANCER

IPC classification:
C12N 15/09, C12M 1/34, C12M 1/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18180710

NOVEL HETEROCYCLIC DERIVATIVES AND THEIR USES

IPC classification:
C07D 519/00, C07D 498/14, C07D 487/14, A61P 35/00, A61P 37/08, A61P 29/00, A61K 31/4985, C07D 471/14
Applicant:
C&C Research Laboratories
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17857586

METHODS FOR MULTI-RESOLUTION ANALYSIS OF CELL-FREE NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17807278

MASS SPECTROMETRY METHOD FOR DETECTION AND QUANTITATION OF METABOLITES

IPC classification:
G01N 33/52, G01N 33/50, G01N 33/49, G01N 33/487, G01N 33/483
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17823190

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

IPC classification:
A61K 39/00, A61P 19/08, A61K 39/395, C07K 16/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP17740185

FEED INGREDIENTS COMPRISING LYSED MICROBIAL CELLS

IPC classification:
A23K 10/22, A23K 10/20, A23K 10/18, A23K 10/16, A23K 10/00
Agent:
De Vries & Metman
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18213124

MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION

IPC classification:
C07K 16/16, A61J 3/07, A61J 3/00, A61K 9/48, A61K 39/35
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP17824931

METHODS FOR FRAGMENTOME PROFILING OF CELL-FREE NUCLEIC ACIDS

IPC classification:
G06F 19/24, G06F 19/22, G06F 19/18, C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18214393

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

IPC classification:
A61P 19/02, A61K 9/00, G01N 33/68, G01N 33/53, A61K 38/44
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP18207391

SYSTEMS AND METHODS TO DETECT COPY NUMBER VARIATION

IPC classification:
G16B 20/10, C12Q 1/6827
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18197338

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

IPC classification:
A61P 35/00, C07K 16/00, C12P 21/08, A61K 39/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Mewburn Ellis LLP
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP18195741

THERAPEUTIC COMBINATION AND USE OF DLL4 ANTAGONIST ANTIBODIES AND ANTI-HYPERTENSIVE AGENTS

IPC classification:
A61P 9/12, A61P 35/00, A61K 39/395
Agent:
Mewburn Ellis LLP
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP19151232

IMPROVED METHODS FOR PREPARING SQUALENE

IPC classification:
C12N 7/00, B01D 3/10, A61K 39/145, A61K 39/00, A61P 31/16, A61K 47/06, A61K 39/39, A61K 31/01, A61K 9/107, C07C 7/04, C07C 11/21
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP17754534

LASER ABLATION SYSTEM

IPC classification:
H01J 49/04
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17844412

ENGINEERED TARGET SPECIFIC NUCLEASES

IPC classification:
A61K 38/16, C12N 9/22, C12N 9/14
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17844404

REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES

IPC classification:
A61K 38/46, A61K 35/12, C12N 15/85, C12N 9/16, C07K 14/47
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP19160889

COMPOSITIONS COMPRISING A BACTERIAL STRAIN OF BLAUTIA FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS OF THE GASTROINTESTINAL TRACT

IPC classification:
A61P 31/04, A61P 1/12, A61P 1/10, A23L 33/135, A61K 9/48, A61K 9/19, A61K 9/00, A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP18209327

METHODS OF SAMPLE PREPARATION

IPC classification:
C12P 19/00, C12Q 1/68
Applicant:
The Scripps Research Institute
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP17785013

TREATING REFRACTORY MIGRAINE

IPC classification:
A61K 39/00, A61P 25/06, C07K 16/18
Applicant:
Teva Pharmaceuticals International GmbH
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17785012

TREATING CLUSTER HEADACHE

IPC classification:
A61P 25/06, A61K 39/395
Applicant:
Teva Pharmaceuticals International GmbH
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP19160892

COMPOSITIONS COMPRISING A BACTERIAL STRAIN OF BLAUTIA FOR USE IN THE TREATMENT OR PREVENTION OF DIARRHEA OR CONSTIPATION

IPC classification:
A61P 31/04, A61P 1/12, A61P 1/10, A23L 33/135, A61K 9/48, A61K 9/19, A61K 9/00, A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP18213690

PRODUCTION OF TAILORED OILS IN HETEROTROPHIC MICROORGANISMS

IPC classification:
C10L 1/02, C12N 15/79, C12N 9/16, C12N 9/00, C12P 7/64, C12P 7/20, C12P 21/06
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP19161713

COMPOSITIONS COMPRISING BACTERIAL BLAUTIA STRAINS FOR TREATING VISCERAL HYPERSENSITIVITY

IPC classification:
A61P 29/00, A61P 1/14, A61K 9/00, A61K 35/741
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP19161691

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61P 29/00, A61P 1/14, A61K 35/74
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP18212337

GENETICALLY-ENGINEERED CHLORELLA OR PROTOTHECA MICROBE AND OIL PRODUCED THEREFROM

IPC classification:
C12N 9/16, H01F 27/12, H01B 3/22, C12P 7/64, C11B 1/02
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP19163403

METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTS

IPC classification:
C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The application has been published
EP17860451

DETERMINING CELL TYPE ORIGIN OF CIRCULATING CELL-FREE DNA WITH MOLECULAR COUNTING

IPC classification:
C12Q 1/6883, C12Q 1/6881
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17861799

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE

IPC classification:
C12P 21/06, C12N 15/87, C12N 15/00, A61K 48/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17864858

METHODS AND COMPOSITIONS FOR PREVENTING VECTOR-BORNE DISEASE TRANSMISSION

IPC classification:
A61K 31/341, A61K 31/135, A61K 31/12
Applicant:
The Scripps Research Institute
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17869608

COMBINATION THERAPIES OF PREDNISONE AND URICASE MOLECULES AND USES THEREOF

IPC classification:
A61P 37/00, A61K 31/56, A61K 38/44
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17869399

POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE

IPC classification:
C12Q 1/04, C12P 19/34, C12N 15/11, C12N 15/09, C07H 21/04, C07H 21/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17872045

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS ENCODING METHYL-CPG BINDING PROTEIN 2

IPC classification:
C12N 7/00, C07K 14/47, A61K 48/00
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17868914

POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF CHLAMYDIA TRACHOMATIS

IPC classification:
C07H 21/04, C12Q 1/68
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17876358

METHODS FOR TREATMENT OF CANCER COMPRISING TIGIT-BINDING AGENTS

IPC classification:
C07K 14/47, C07K 5/12, C07K 5/10, A61P 35/00, A61K 39/395, A61K 39/00
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17876620

TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF

IPC classification:
C12N 9/22, C12N 15/11, C12N 15/00
Applicant:
Massachusetts General Hospital
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18705030

ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGF 1 INHIBITORS AND USE THEREOF

IPC classification:
A61P 37/00, A61P 35/00, C07K 16/22
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17828700

METHODS OF DETERMINING COLORECTAL CANCER STATUS IN AN INDIVIDUAL

IPC classification:
C12Q 1/68
Applicant:
University College Cork (University College Cork)
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17885159

MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES

IPC classification:
H01J 49/26, G01N 33/68, G01N 33/483, G01N 30/72
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP19170925

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61P 35/00, A61K 35/74
Applicant:
4D Pharma Research Ltd.
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP18701237

METHODS FOR TREATING METABOLIC DISEASES BY INHIBITING MYOSTATIN ACTIVATION

IPC classification:
A61K 39/00, A61P 25/00, A61P 21/06, A61P 21/00, A61P 9/10, A61P 9/00, A61P 5/50, A61P 3/10, A61P 3/08, A61P 3/06, A61P 3/04, A61P 3/00, C07K 16/22, A61K 39/395
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18739367

METHODS OF MANUFACTURE OF NUT FLOURS AND FORMULATIONS FOR ORAL IMMUNOTHERAPY

IPC classification:
A23L 7/10, A23L 5/20
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18739104

CONSTRUCTS TARGETING HISTONE H3 PEPTIDE/MHC COMPLEXES AND USES THEREOF

IPC classification:
G01N 33/574, A61K 39/395, C07K 16/30, C07K 16/28, C12N 15/85, C12N 5/0783
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature